LBF20408LX01: Difference between revisions
No edit summary |
No edit summary |
||
| (18 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
| Line 4: | Line 6: | ||
|LipidBank=DFA8154 | |LipidBank=DFA8154 | ||
|LipidMaps=LMFA03040002 | |LipidMaps=LMFA03040002 | ||
|SysName=5S,14R,15S- | |SysName=(5S,14R,15S) -Trihydroxy- (trans-6,cis-8,trans-10,trans-12) - eicosatetraenoic acid | ||
|Common Name=&& | |Common Name=&&Lipoxin B_4&&(5S,14R,15S) -Trihydroxy- (6E,8Z,10E,12E) - eicosatetraenoic acid | ||
|UV Spectra= | |UV Spectra= lambda max: 302nm epsilon : 50,000 | ||
|Source=LXB4 is a trihydroxy fatty acid containing a conjugated tetraene, isolated when arachidonic acid is incubated with A23187-stimulated mixtures of human platelets and granulocytes [[Reference:Edenius_C:Stenke_L:Lindgren_JA:,Eur. J. Biochem.,1991,199,401|{{RelationTable/GetFirstAuthor|Reference:Edenius_C:Stenke_L:Lindgren_JA:,Eur. J. Biochem.,1991,199,401}}]]. | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Symbol=LXB4 | |||
|Biological Activity=It is associated with several biological functions including leukocyte activation, natural killer cell inhibition, and monocyte migration and adhesion [[Reference:Ramstedt_U:Serhan_CN:Nicolaou_KC:Webber_SE:Wigzell_H:Samuelsson_B:,J. Immunol.,1987,138,266|{{RelationTable/GetFirstAuthor|Reference:Ramstedt_U:Serhan_CN:Nicolaou_KC:Webber_SE:Wigzell_H:Samuelsson_B:,J. Immunol.,1987,138,266}}]][[Reference:Maddox_JF:Serhan_CN:,J. Exp. Med.,1996,183,137|{{RelationTable/GetFirstAuthor|Reference:Maddox_JF:Serhan_CN:,J. Exp. Med.,1996,183,137}}]]. | |||
}} | }} | ||
{{Lipid/Footer}} | |||
Latest revision as of 07:55, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8154 |
| LipidMaps | LMFA03040002 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20408LX01 |
| Lipoxin B4 | |
|---|---|
| |
| Structural Information | |
| (5S,14R,15S) -Trihydroxy- (trans-6,cis-8,trans-10,trans-12) - eicosatetraenoic acid | |
| |
| LXB4 | |
| Formula | C20H32O5 |
| Exact Mass | 352.224974134 |
| Average Mass | 352.46508 |
| SMILES | C(CCC(O)C(O)C=CC=CC=CC=CC(CCCC(O)=O)O)CC |
| Physicochemical Information | |
| LXB4 is a trihydroxy fatty acid containing a conjugated tetraene, isolated when arachidonic acid is incubated with A23187-stimulated mixtures of human platelets and granulocytes Edenius_C et al.. | |
| It is associated with several biological functions including leukocyte activation, natural killer cell inhibition, and monocyte migration and adhesion Ramstedt_U et al. Maddox_JF et al.. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | λ max: 302nm ε : 50,000 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
